Localised lockdowns have affected sales in second Covid wave, says Jyothy Labs
According to Ullas Kamath, Joint MD, operations such as stock replenishment, and sales have to be worked within a short time frame20-05-2021
Localised lockdowns have affected sales in second Covid wave, says Jyothy Labs
According to Ullas Kamath, Joint MD, operations such as stock replenishment, and sales have to be worked within a short time frameJyothy Labs Q4 is muted; near-term outlook isn't bright either
Overall, Jyothy Labs saw 400 basis points year-on-year expansion in its Ebitda margin.But Ebitda margin has contracted by 240 basis points vis--vis the December quarterEarnings Call for Q4FY21 of Jyothy Labs
Conference Call with Jyothy Labs Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.Jyothy Labs Q4 profit up 3% at Rs 27 crore
It had posted a net profit of Rs 26.59 crore in January-March 2019-20.Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation
Enclosed herewith is the presentation to be made at the Analyst meet to be held today i.e. May 18, 2021 on Company's performance for the quarter and financial year ended March 31, 2021 and the way forward.Jyothy Labs Ltd - 532926 - Book Closure For Payment Of Dividend And Annual General Meeting
The Register of Member and Share Transfer Books of the Company will remain closed from Friday, July 23, 2021 to Friday, July 30, 2021 (both days inclusive) for taking record of the members of the Company who are eligible for the purpose of payment of dividend and for the 30th Annual General Meeting of the Company.Jyothy Labs Ltd - 532926 - Corporate Action-Board approves Dividend
The Board of Directors at its Meeting held today recommended a Dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re.1/- each for the financial year 2020-21 and fixed the date of 30th Annual General Meeting of the Company as Friday, July 30, 2021.Jyothy Labs Ltd - 532926 - Results - Audited Financial Results For Quarter And Year Ended March 31, 2021
Standalone and Consolidated Audited Financial Results of the Company along with the Auditors Report for the quarter and year ended March 31, 2021Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Loss of Share Certificate